Lantheus Holdings Inc. (LNTH)
NASDAQ
Closed
Oct 7, 2026
Day's Range
100.0252 wk Range
49.67Overview - LNTH - Lantheus Holdings Inc.
Key Statistics
Valuation
Enterprise Value
6.55B
P/E (Trailing)
‪23.91‬
P/E (Forward)
‪15.67‬
PEG Ratio
‪15.67‬
Price / Sales (TTM)
‪4.19‬
Price / Book
‪4.97‬
EV / EBITDA
‪16.71‬
Profitability
Gross Margin
‪62.30%‬
Profit Margin
‪17.69%‬
Operating Margin
‪25.81%‬
Return on Assets
‪8.37%‬
Return on Equity
‪22.21%‬
Ownership
Shares Outstanding
65.26M
Float
58.61M
Short % of Shares Outstanding
‪7.23%‬
Held by Insiders
‪1.73%‬
Held by Institutions
‪116.75%‬
Price stats
Beta
‪-0.03‬
50-Day Avg
‪100.78‬
200-Day Avg
‪88.07‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 107.04‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LNTH - Lantheus Holdings Inc.
Peers - LNTH - Lantheus Holdings Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- LNTHNASDAQLantheus Holdings Inc.6.52BMarket Cap+47.28%52-week change23.91P/E (Trailing)‪17.69%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences, Inc.14.55BMarket Cap+2.62%52-week change20.93P/E (Trailing)‪20.91%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals, Inc.7.07BMarket Cap+48.03%52-week change42.29P/E (Trailing)‪5.04%‬Profit Margin
- ALKSNASDAQAlkermes plc7.00BMarket Cap+25.77%52-week change109.87P/E (Trailing)‪3.96%‬Profit Margin
- KNSANASDAQKiniksa Pharmaceuticals International, plc Class A Ordinary Shares5.83BMarket Cap+49.48%52-week change76.56P/E (Trailing)‪9.59%‬Profit Margin
- DIODNASDAQDiodes Incorporated4.43BMarket Cap+44.79%52-week change51.08P/E (Trailing)‪5.26%‬Profit Margin
- INDVNASDAQIndivior Pharmaceuticals, Inc.4.21BMarket Cap+36.35%52-week change12.68P/E (Trailing)‪26.74%‬Profit Margin
Profile Summary - LNTH - Lantheus Holdings Inc.
About
Lantheus Holdings Inc. is a radiopharmaceutical-focused healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products used to help clinicians detect, localize, and monitor disease. Its portfolio centers on precision diagnostics and nuclear medicine solutions for oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
